83
55
Growth Score
-2 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
595894
ProStrakan is a pharmaceutical company.
Acquired by 
Kyowa Kirin
- Masashi Miyamoto: President and CEOPast Role: Kyowa Kirin, Chief Executive Officer
About the Company
ProStrakan is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major markets.
With more than 300 people employed by the Company, ProStrakan is headquartered in Scotland with commercial operations throughout the rest of
the UK and continental Europe and a US head office. The Company's Development group is located in Galashiels, Scotland and Bedminster, New Jersey, US.
